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Group II innate lymphoid cells and
microvascular dysfunction from pulmonary
titanium dioxide nanoparticle exposure
Alaeddin Bashir Abukabda1,2, Carroll Rolland McBride1,2, Thomas Paul Batchelor1,2, William Travis Goldsmith1,2,
Elizabeth Compton Bowdridge1,2, Krista Lee Garner1,2, Sherri Friend3 and Timothy Robert Nurkiewicz1,2,3*

Abstract
Background: The cardiovascular effects of pulmonary exposure to engineered nanomaterials (ENM) are poorly
understood, and the reproductive consequences are even less understood. Inflammation remains the most
frequently explored mechanism of ENM toxicity. However, the key mediators and steps between lung exposure and
uterine health remain to be fully defined. The purpose of this study was to determine the uterine inflammatory and
vascular effects of pulmonary exposure to titanium dioxide nanoparticles (nano-TiO2). We hypothesized that
pulmonary nano-TiO2 exposure initiates a Th2 inflammatory response mediated by Group II innate lymphoid cells
(ILC2), which may be associated with an impairment in uterine microvascular reactivity.
Methods: Female, virgin, Sprague-Dawley rats (8–12 weeks) were exposed to 100 μg of nano-TiO2 via intratracheal
instillation 24 h prior to microvascular assessments. Serial blood samples were obtained at 0, 1, 2 and 4 h post-exposure
for multiplex cytokine analysis. ILC2 numbers in the lungs were determined. ILC2s were isolated and phosphorylated
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB) levels were measured. Pressure myography was
used to assess vascular reactivity of isolated radial arterioles.
Results: Pulmonary nano-TiO2 exposure was associated with an increase in IL-1ß, 4, 5 and 13 and TNF- α 4 h postexposure, indicative of an innate Th2 inflammatory response. ILC2 numbers were significantly increased in lungs from
exposed animals (1.66 ± 0.19%) compared to controls (0.19 ± 0.22%). Phosphorylation of the transactivation
domain (Ser-468) of NF-κB in isolated ILC2 and IL-33 in lung epithelial cells were significantly increased (126.8 ± 4.3%
and 137 ± 11% of controls respectively) by nano-TiO2 exposure. Lastly, radial endothelium-dependent arteriolar
reactivity was significantly impaired (27 ± 12%), while endothelium-independent dilation (7 ± 14%) and α-adrenergic
sensitivity (8 ± 2%) were not altered compared to control levels. Treatment with an anti- IL-33 antibody (1 mg/kg)
30 min prior to nano-TiO2 exposure resulted in a significant improvement in endothelium-dependent dilation and a
decreased level of IL-33 in both plasma and bronchoalveolar lavage fluid.
Conclusions: These results provide evidence that the uterine microvascular dysfunction that follows pulmonary ENM
exposure may be initiated via activation of lung-resident ILC2 and subsequent systemic Th2-dependent inflammation.
Keywords: Engineered nanomaterials, Titanium dioxide nanoparticles, Microcirculation, Innate lymphoid cells, Inflammation

* Correspondence: tnurkiewicz@hsc.wvu.edu
1
Department of Physiology and Pharmacology, West Virginia University
School of Medicine, 64 Medical Center Drive, Robert C. Byrd Health Sciences
Center - West Virginia University, Morgantown, WV 26505-9229, USA
2
Toxicology Working Group, West Virginia University School of Medicine,
Morgantown, WV, USA
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Abukabda et al. Particle and Fibre Toxicology

(2018) 15:43

Introduction
Reproductive toxicity is increasingly becoming recognized as a critical aspect of ENM safety. However, the
effects of ENM exposure on overall reproductive health
have only recently been addressed and become a focus
of intense study by numerous groups [1, 2]. As with
other observations of systemic biologic effects after pulmonary ENM exposures, reproductive effects are equally
susceptible but poorly understood. Our group has previously reported that nano-TiO2 inhalation is associated
with uterine microvascular dysfunction [3], potentially
deleterious epigenomic alterations [4], and cognitive deficits in maternally exposed progeny [5]. While these
studies highlight the importance of identifying the maternal effects of ENM exposure, the mechanisms linking
such exposures to these negative reproductive and developmental outcomes have yet to be fully elucidated.
In the last decade, innate lymphoid cells (ILC) have
emerged as a novel population of tissue-specific effector
cells with the ability to initiate and regulate the innate
and adaptive branches of the immune system [6, 7]. ILCs
are now divided into 3 distinct groups according to the
pattern of cytokine secretion; Group 1 ILC (ILC1) are
predominantly tissue-resident cells capable of secreting
interferon gamma (IFN- γ) in the liver, gut, spleen, skin,
peritoneum, and salivary gland [8]. The role played by
ILC1 in various immunological conditions remains unclear but is currently under investigation. Group 2 ILCs
(ILC2, also known as nuocytes, natural helper cells)
secrete IL-4, IL-5, IL-9, and IL-13 in response to
damage-associated molecular patterns or “alarmins” and
have been implicated in the immune response to parasitic
infections and in allergic airway inflammation [9] to several environmental and anthropogenic agents [10, 11].
Lastly, group 3 ILCs (ILC3) produce IL-22 and or IL-17,
are enriched at mucosal sites, contribute to the maintenance of the intestinal barriers, and may play a significant
role in the promotion of the inflammatory response and
etiology of inflammatory bowel diseases [12, 13]. One of
the most important alarm signals secreted by cells is
interleukin-33 (IL-33) [14]. IL-33 is a member of the IL-1
family of cytokines expressed by both non-immune cells
such as epithelial, endothelial, smooth muscle cells, and fibroblasts [15], as well as immune effector cells including
macrophages and dendritic cells. Its role in directing the
inflammatory response following pulmonary exposure to
carbon nanotubes [16–18], and ozone [19] have been previously reported. IL-33 has been demonstrated [20] to induce the release of Th2 cytokines by immune cells
including ILC2s in asthmatic patients [21], and to induce
airway hyperresponsiveness and increased pulmonary resistance [22, 23].
In view of the increasing number of studies indicating
a crucial role for ILCs in the initiation of the acute
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inflammatory response to environmental agents, the goal
of this work was to provide initial evidence of their
potential involvement in the response to pulmonary
ENM exposure. Therefore, the purpose of this study was
threefold. First, we identified the inflammatory and
uterine microvascular effects associated with acute
pulmonary nano-TiO2 exposure. Second, we determined
the possible role played by ILC in the immune response
mounted to acute pulmonary nano-TiO2 exposure.
Lastly, the microvascular and systemic effects of treatment with an IL-33 antibody (a key activator of ILC2)
were determined. We hypothesized that pulmonary
nano-TiO2 exposure initiates a Th2 inflammatory
response mediated involving IL-33 and potentially involving ILC2, which may be associated with a systemic
impairment in uterine microvascular reactivity.

Results
SEM images and mass spectrometry of Nano-TiO2

Figure 1 shows field-emission scanning electron microscope
images (Hitachi S4800, Tokyo, Japan) of the nano-TiO2 suspension used for this study. As seen in Fig. 1a, the suspended
particles present significant agglomeration. Figure 1b shows
the elemental composition of the nano-TiO2 suspension
(Bruker, Billerica, MA), indicating the prevalent presence of
titanium.
Animal and vessel characteristics

No significant changes were observed in age, mean arterial
pressure (MAP), heart rate and body weight between control
and exposure groups (Table 1). Additionally, radial arteriolar
inner and outer diameter, tone, passive diameter, wall thickness, wall to lumen ratio and calculated wall tension were
not affected by nano-TiO2 exposure and treatment with an
anti-IL-33 antibody (Table 2). From these results we can infer
that acute nano-TiO2 exposure does not alter vascular tone
or the balance of its contributing influences.
Acute plasma and BALF cytokine secretion patterns
following pulmonary Nano-TiO2 exposure

A time-course study was initially performed to identify the
temporal effect of nano-TiO2 on cytokine secretion. Plasma
samples were obtained at 0,1,2, and 4 h following
nano-TiO2 exposure by tail vein puncture. Figure 2 shows
the results of the multiplex analysis. No differences existed
at time 0, 1 or 2 h post-exposure. However, significant differences were detected 4 h post-exposure in plasma levels
of the pro-inflammatory cytokines IL-4, IL-5, IL-13, TNF-α,
IL-1β, while no alterations in the cytokines IFN-γ, KC/
GRO, TNF-α, IL-10, IL-6, MCP-1, TIMP-1, Lipocalin-2,
and TSP-1 were noted (Data not shown).
In order to confirm the results observed in the plasma,
the cytokine levels in the BALF were also measured 4 h
post-exposure. Multiplex analysis of the BALF (Fig. 3)
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Fig. 1 Characterization of Nano-TiO2. (a) SEM image and (b) Energy dispersive spectroscopy showing elemental composition of the nano-TiO2
suspension used in this study

also showed an almost 5-fold increase in IL-5 and a
6-fold increase in IL-4, IL-13, TNF-α, and IL-1β, while
no changes were seen in the other cytokines (Data not
shown). Based on the collective cytokine profile associated with this exposure paradigm, the results provide
evidence that acute pulmonary nano-TiO2 exposure may
trigger a T-Helper cell type 2 (Th2) response beginning
4 h post-exposure.

IL-33 secretion by lung epithelial cells pre- and post- exposure
and following treatment with an anti-IL-33 antibody

IL-33 plays a significant role in initiating and modulating
lung inflammatory and immunological responses [24], by
inducing the secretion of Th2 pro-inflammatory cytokines.
It is constitutively present in mucosal epithelial cells and
acts as a “danger” signal after tissue injury by activating immune cells. To determine the effect of nano-TiO2 on pulmonary and plasma IL-33 levels, immunohistochemistry of
tracheal sections was conducted 4 h post-exposure. In a
separate cohort of control and exposed animals, multiplex
analysis of plasma and BALF IL-33 was also performed 4 h
post-exposure. Figure 4 shows representative images of
lung sections from control and exposed rats stained for
IL-33 4 h post-exposure and the quantitative measurements
for both groups. Relative fluorescence intensity of IL-33
was significantly increased in exposed animals by 26.8 ±
4.3%, while plasma and BALF levels indicated a 37.87 ±
2.3% and 171.26 ± 13% increase in IL-33 respectively (Fig. 5).
Interestingly, treatment 1 h prior to exposure to nano-TiO2
with pharmacological grade polyclonal anti-IL-33 antibody
(EMD Millipore, Temecula, CA: intraperitoneal 1 mg/kg)
resulted in a decrease in plasma and BALF IL-33 levels 4 h

post-exposure (61.1 ± 2.1% in plasma and 149.7 ± 7% in
BALF) when compared to nano-TiO2 exposed and untreated animals. The results herein described provide evidence that reveals the critical role played by IL-33 in the
initiation of the inflammatory response to ENM.
Flow cytometric analysis of ILC1 and ILC2

Polarization of T-cells requires several days [25], therefore,
the early appearance of Th2 cytokines in the circulation after
nano-TiO2 suggests that other, more rapid immune effector
cells may be involved. Previous work has indicated that both
ILC1 and ILC2 [26, 27] reside in the lungs and may be involved in lung inflammatory responses and pathology.
Therefore, we next wanted to determine the effect of
nano-TiO2 exposure on ILC1 and ILC2 levels in the lungs.
For this reason, multi-parametric flow cytometric analysis
was conducted on lung tissue from control and nano-TiO2
exposed Sprague-Dawley rats for ILC1 (Data not shown) and
ILC2 (Fig. 6) 4 h post-exposure. No significant differences
were noted in ILC1 levels pre- and post- exposure while
ILC2 levels increased from 0.19 ± 0.22% to 1.66 ± 0.19%
(Fig. 7a and b).
NF-ĸB phosphorylation and Th2 cytokine secretion by
isolated ILC2

Activation of the NF-κB pathway has been shown to play
a role in inflammation through its ability to induce the
transcription of proinflammatory genes [28, 29]. Specifically, phosphorylation of NF—ĸB at both serine residues
468 and 536 are associated with inflammatory response
[29, 30]. Therefore, levels of phospho- NF—ĸB were
measured in isolated ILC2 from control and nano-TiO2

Table 1 Animal characteristics
N
Control

Age (weeks) weight (grams) Heart Rate (bpm) Map (mm Hg) Systolic Blood pressure (mm Hg) Diastolic Blood Pressure (mm Hg)

13 14 ± 1

Exposed 14 15 ± 1

232 ± 5

319 ± 13

85 ± 3

103 ± 4

73 ± 2

249 ± 12

330 ± 9

86 ± 4

110 ± 6

78 ± 4

Table showing characteristics of control (N = 13) and exposed groups (N = 14). Values shown are mean ± SEM. Statistics were analyzed with two-way ANOVA (P ≤ 0.05), *
Sham control group vs. nano-TiO2 exposed groups
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Table 2 Arteriolar characteristics

Control

n

Inner diameter (μm)

Outer diameter (μm)

Tone(%)

Passive diameter
inner (μm)

Passive diameter
outer (μm)

Wall Tension
(Newton/meter)

18

98 ± 5

152 ± 14

26 ± 7

152 ± 9

199 ± 15

0.33 ± 0.1

Exposed

16

102 ± 11

164 ± 13

21 ± 4

159 ± 15

207 ± 17

0.34 ± 0.1

Exposed + anti-L-33

12

97 ± 11

158 ± 19

21 ± 4

140 ± 14

187 ± 26

0.31 ± 0.6

Table showing characteristics of control and exposed radial arterioles (n = 12–18). All vascular assessments were performed 24 h post-exposure. Values shown are
mean ± SEM. Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups

exposed animals (Fig. 8). No significant differences were
noted in phosphorylation of the Serine-536 residue between the 2 groups, while phosphorylation of Serine-468
was increased after acute pulmonary nano-TiO2 exposure (128.6 ± 7.24% of control levels).
Lastly, isolated ILC2 were cultured overnight and IL-4,
IL-5 and IL-13 levels in the cell-culture media were measured. Nano-TiO2 resulted in a significant increase in IL-4,
IL-5, and IL-13 (122 ± 7.2%, 141.4 ± 9.1%, 158.8 ± 7.6% of
control levels respectively) (Fig. 9).
Effect of acute pulmonary Nano-TiO2 exposure and
systemic immunotherapy on uterine radial arterioles
Endothelium-dependent dilation

In order to identify the acute reproductive effects associated with nano-TiO2 exposure, radial arterioles were
isolated from the uterus of control and exposed animals
24 h post-exposure and endothelium-dependent and

A

independent dilation along with adrenergic sensitivity
were tested. Previous work by our group has shown
that ENM exposure impacts vascular reactivity most
severely within 24 h, a condition which has been shown
to improve but not fully return to control levels after
168 h [30]. Based on these findings, all vascular assessments for this study were conducted 24 h postexposure.
Endothelium-dependent dilation of radial arterioles was
significantly impaired following intratracheal instillation of
100 μg of nano-TiO2(Fig. 10), with a mean decrease in dilation of 49.23 ± 6.5% compared to controls and 24.35 ± 10%
compared to anti-IL-33 antibody-treated rats. These results
suggest that pulmonary nano-TiO2 exposure disrupts normal physiological vascular endothelial function and that
pre-treatment with an anti-IL-33 antibody partially attenuates the systemic acute inflammatory cascade triggered by
lung-derived IL-33.

B

D

C

E

Fig. 2 Nano-TiO2 exposure increases T-Helper type II cytokines 4 h post-exposure. Multiplex cytokine analysis showing concentrations of IL-4 (a), IL-1β (b),
TNF-α (c), IL-13 (d) and IL-5 (e). Serum samples were obtained at 0, 1, 2 and 4 h post-exposure via tail-vein puncture (N = 6). Statistics were analyzed with
two-way ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups
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Fig. 3 Nano-TiO2 exposure also increases T-Helper type II cytokines 4 h post-exposure in bronchoalveolar lavage fluid (BALF). Multiplex cytokine
analysis showing concentrations of IL-4, IL-5, IL-13 in BALF from exposed and control animals 4 h post-exposure (N = 6). Statistics were analyzed
with two-way ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups

In contrast to endothelium-dependent relaxation, no
point to point differences were seen in α-adrenergic and
endothelium-independent dilation between control, nanoTiO2 exposed, and treated groups (Data not shown).

Discussion
The inflammatory paradigm tested herein has been suggested by previous studies [16, 31, 32]. While these
studies explored pulmonary responses to exogenously

administered IL-33, carbon nanotubes and viral infection, our findings provide additional evidence of a similar link between acute pulmonary ENM exposure and
subsequent inflammatory mechanisms with systemic
microvascular consequences. Perhaps the most important finding of this study is the identification of IL-33 as
a potential contributor to the systemic inflammatory
phenotype and microvascular dysfunction resulting
from acute pulmonary ENM exposure.

Fig. 4 Nano-TiO2 exposure is associated with an increase in pulmonary interleukin-33 levels. Lung sections from control (a) and nano-TiO2
exposed (b) animals obtained 4 h post-exposure were stained for interleukin-33. Fluorescence was achieved by staining tracheal sections with an
anti-IL-33-FITC conjugated antibody. Relative fluorescence is shown in (c) tagged antibody (N = 6–7). Statistics were analyzed with two-way
ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups
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Fig. 5 Pre-treatment of nano-TiO2 – exposed animals with an anti-IL-33 antibody lowers BALF and plasma IL-33. Interleukin-33 levels in (a) BALF
and (b) plasma in control, nano-TiO2 exposed groups and in rats pre-treated with an anti-IL-33 antibody. Rats were pre-treated with an anti-IL-33
antibody (1 mg/kg) 30 min prior to exposure. Plasma and BALF IL-33 levels were measured 4 h post-exposure. Statistics were analyzed with two-way
ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups, Ŧ P < 0.05 Exposed + Anti-IL-33 Antibody vs Exposed

We hypothesized that the innate response to pulmonary
nano-TiO2 exposure is triggered by the secretion of IL-33
by lung epithelial cells. IL-33, a member of the IL-1 family,
plays a significant role in initiating and modulating lung
inflammatory and immunological responses [33], by inducing the secretion of Th2 pro-inflammatory cytokines
through the Suppression of Tumorigenicity 2 (ST2) receptor in a variety of immune cells [32, 34]. Previous studies
have shown that exposure to multi-walled carbon nanotubes triggers the IL-33/ST2 axis leading to the activation
of mast-cells and macrophages [20]. Interestingly, IL-33 is
also required for the maturation, activation and egress of
ILC2 lineage cells from the bone marrow to specific target

organs [35]. Several previous studies by our group and
others have extensively investigated the cardiovascular effects of pulmonary ENM exposure [36, 37]. These studies
consistently reveal that nano-TiO2 exposure increases
leukocyte activation [38], proinflammatory mediators [39],
and oxidative stress [40]. Collectively, this results in
endothelium-dependent dysfunction. ILCs are a recently
identified subpopulation of immune effector cells [33, 41].
They are critical, non-cytolytic tissue-resident cells that
can be activated and respond acutely to danger signals or
“alarmins” such as IL-33 from mucosal tissue by producing a distinctive array of cytokines to maintain mucosal
integrity. Group II ILCs specifically, secrete the cytokines

A)

B)

Fig. 6 Flow cytometric analysis of lung-resident Group II innate lymphoid cells. Flow cytometry of lung tissue 4 h post-exposure for Group II
Innate Lymphoid Cells in (a) control and (b) nano-TiO2 exposed animals (N = 6)
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Fig. 7 Nano-TiO2 exposure increases pulmonary ILC2 but not ILC1. Quantification of percentage of total pulmonary cells of (a) ILC1 and (b) ILC2
in control and nano-TiO2 exposed animals (N = 6). Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2
exposed groups

IL-5, IL-13, IL-9, amphiregulin, and low quantities of IL-4
[31] and have been linked to several lung-associated conditions including pathogen infections (viruses and helminths), asthma, and pulmonary fibrosis [42]. Lung ILC2
have an important role in regulating tissue remodeling
and repair during acute epithelial injury and asthma [43].
Considered together, it is reasonable to speculate that the
IL-33/ILC2 axis may impact systemic microvascular function after pulmonary ENM exposure.
Perhaps, the most significant finding of this study is
the identification of a potential role for IL-33 in the initiation of an acute inflammatory response and the effects
on systemic microvascular dysfunction (Fig. 10). This
was achieved by interrupting the IL-33/ST2 signaling
axis with an anti-IL-33 antibody treatment prior to
ENM exposure. In these experiments, the control group
(IT saline) did not receive the anti-IL-33 antibody. The
scientific rationale for this decision was that the technique (isolated, perfused and pressurized arterioles) used
to assess microvascular dysfunction is a plasma free system.
As such, it was impossible to assess the role of the complete
IL-33/ST2 axis on arteriolar tone and/or reactivity. Whereas,

this approach directly measured the impact that IL-33 inflammatory signaling has on microvascular function. It remains a distinct possibility that the IL-33/ST2 axis activated
by pulmonary ENM exposure directly influences microvascular tone and/or reactivity. IL-33 expression has been
identified in human vascular endothelial cells; whereas, is
absent in murine vascular tissue [44]. This supports our postulate that IL-33 is impacting microvascular function via inflammation, rather than a direct activation of the ST2
receptor. Future in vivo studies must directly assess the impact of circulating IL-33 on microvascular tone, reactivity
and blood flow.
While our study provides plausible mechanistic insights
into both the inflammatory and microvascular effects associated with ENM exposure, additional considerations as well
as the limitations must be kept in mind. ENM exposure has
been shown to affect other innate immune effector cells
such as neutrophils [45, 46], macrophages [47, 48], and dendritic cells [49]. Therefore, other mechanisms including local
generation of reactive of oxygen species, secretion of chemokines and prostaglandins by macrophages and stimulation of
the adaptive immune system by antigen-presenting cells

Fig. 8 Nano-TiO2 exposure increases NF-ĸB phosphorylation at Serine-468 in isolated ILC2. Quantification of NF-ĸB phosphorylation at (a) serine468 and (b) serine 536 in isolated ILC2 from isolated. ILC2 from control and nano-TiO2 exposed animals (N = 6). Statistics were analyzed with twoway ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups
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Fig. 9 Th2 cytokine secretion in isolated ILC2 is increased by nano-TiO2 exposure. Multiplex cytokine analysis showing concentrations of IL-4, IL-5,
IL-13 supernatant from isolated ILC2 cultured overnight from control and nano-TiO2 exposed animals (N = 6). Statistics were analyzed with two-way
ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups

may play a role in the systemic inflammatory response and
vascular effects seen in this study. It is also worth noting
that in this study an immune response associated with pulmonary ENM exposure was observed as early as 4 h
post-exposure, as evidenced not only by an increase in the
proportion of lung-resident ILC2s (Fig. 7), but also by augmented levels of the Th2 cytokines IL-4, IL-5, and IL-13
(Figs. 2 and 3). This response timeframe is in agreement

with previous studies, that have reported IL33, ILC2 numbers as well as lung and serum Th2 cytokines increase
within 6–12 h of lung injury [50, 51]. Furthermore, isolated
ILC2s have been shown to respond dose-dependently to
transient or continuous stimulation with IL-2 and/or IL-33
within 3 h [52]. Similarly, nano-TiO2 instillation at lung
burdens of 40–160 μg/rat has also been shown to increase
BALF inflammatory mediators within 4 h of exposure [53].

Fig. 10 Endothelium-dependent dilation of radial arterioles is blunted by nano-TiO2 exposure and improved by pre-treatment with an anti-IL-33
antibody. Endothelium-dependent dilation of uterine radial arterioles from control, exposed and anti-IL-33 antibody treated animals was
determined using pressure myography (n = 12–18). All vascular assessments were performed 24 h post-exposure. Statistics were analyzed with
two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups, Ŧ P < 0.05 Exposed + Anti-IL-33 Antibody vs Exposed
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We report herein a similar phenomenon as the lung
burden used in this study was comparable at 100 μg/rat.
Our findings contribute consistent evidence for a role
of ILC2s in the acute pulmonary response to ENM exposure. Due to the inherent limitations associated with
our experimental in vivo model, we were unable to directly establish causality. In order to directly confirm
such an observation, ILC2 deletion would be necessary.
Our research program has a long-standing interest in
the systemic microvascular consequences of pulmonary
particle exposure. Rat models are primarily used in our
in vivo studies as they are the most appropriate and
widely used animals for microvascular research. However, they are not commonly or easily adapted for transgenic studies. As such, an ILC2 rat deletion model does
not exist. If such a model were created in the future, it
would then be possible to directly confirm a causative
relationship between ENM exposure and ILC2 activation, proliferation and recruitment.
Lastly, to allow periodic blood sampling for cytokine
analysis, intratracheal instillation was chosen as the preferred exposure method. The above-mentioned dose of
nano-TiO2 was selected based on previous studies conducted by our group which have shown that it is associated with significant microvascular impairment, oxidative
and nitrosative stress and alveolar macrophage recruitment [36, 54]. Additionally, to better understand the relevance of the exposure paradigm used in this study to
humans, alveolar surface areas must be known [55]. The
rat alveolar surface area is 0.4 m2/lung. Therefore, the rat
burden of 50 μg/lung would result in 125 μg/m2. Given
that the human alveolar surface area is 102 m2, the
equivalent human burden of this exposure paradigm
would be 12.75 mg. The next logical question is: How long
would it take to achieve this burden in humans? In this regard, lung burden may be calculated as:
nano‐TiO2 aerosol concentration  minute ventilation
 exposure duration deposition fraction;
with the following values:
25:5 mg ¼ nano‐TiO2 aerosol concentration
 7600 ml= min ð8 hrh=day  60 min=hr Þ
 14%;
and therefore:
25:5 mg ¼ nano‐TiO2 aerosol concentration
 0:51 m3 =day:
Considering both the National Institute for Occupational Safety and Health (NIOSH) and the Occupational
Safety and Health Administration (OSHA) Permissible
Exposure Limit (0.3 mg/m3 and 5 mg/m3 respectively)
[4], it would require 0.34 working years or 122 working
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days for a human to achieve similar exposure levels to
those used in this study.

Conclusion
In conclusion, the current study provides novel evidence
that links acute pulmonary ENM exposure and systemic
microvascular effects. Because this inflammatory link exists between the lung and the uterine microcirculation, it
remains to be determined if such an axis extends to the
placenta and or fetus.
Materials and methods
Nanomaterial characterization

Nano-TiO2 P25 powder, obtained from Evonik (Aeroxide
TiO2, Parsippany, NJ), has previously been shown to be
a mixture composed primarily of anatase (80%) and
rutile (20%) TiO2, with a primary particle size of 21 nm
and a surface area of 48.08 m2/g [54], and a Zeta-potential of − 56.6 mV [56]. Elemental composition analysis of
the nano-TiO2 suspension was conducted via energy dispersive spectroscopy.
Scanning electron microscopy was performed by diluting
the nano-TiO2 1:100 with filtered distilled water. 0.5 ml of
the diluted particle solution was filtered onto a 0.2 μm polycarbonate filter. A wedge-shaped portion of the polycarbonate filter was mounted onto carbon double stick tape which
was affixed to a 13 mm aluminum stub. The sample was
sputter coated with gold-palladium for two minutes. The
sample was imaged using a Hitachi S4800 field-emission
scanning electron microscope (Tokyo, Japan).
Experimental animals and exposure

Female (8–10 weeks) Sprague – Dawley rats were purchased from Hilltop Laboratories (Scottdale, PA) and
housed in an AAALAC approved facility at West Virginia
University (WVU) with 12:12 h light – dark cycle and regulated temperature. Rats were allowed ad libitum access
to food and water. All procedures were approved by the
Institutional Animal Care and Use Committee of WVU.
100 μg of nano-TiO2 were suspended in 250 μL of vehicle (Normosol and 5% fetal bovine serum) for intratracheal instillation (IT) 24 h prior to experimentation.
Nano-TiO2 suspensions were sonicated for 1 min to ensure homogenous distribution of nanoparticles. Rats
were anesthetized using 5% isoflurane and placed on a
mounting stand. 250 μL of the nano-TiO2 suspension
was then instilled intratracheally. Sprague - Dawley rats
instilled with 250 μL of vehicle were used as controls.
Mean arterial pressure (MAP) acquisition

Rats were anesthetized with isoflurane gas (5% induction, 2–3.5% maintenance). The animals were placed on
a heating pad to maintain a 37 °C rectal temperature.
The trachea was intubated to ensure an open airway and
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the right carotid artery was cannulated to acquire mean
arterial pressure (MAP). The MAP was measured via a
pressure transducer and recorded by PowerLab830 (AD
Instruments, Colorado Springs, CO).
Multiplex cytokine panels of serum and Bronchoalveolar
lavage fluid

Whole blood (1–2 ml) was collected via tail vein puncture
from exposed and control animals at time 0, 1 h, 2 h, and
4 h after exposure into EDTA vacutainers and centrifuged
(1000 x g) to collect plasma which was flash-frozen in liquid
nitrogen and stored at − 80°C until analysis. Rats were euthanized and tissues harvested for further analysis. Multi-spot
inflammatory assays were completed per manufacturer’s
directions (Meso Scale Diagnostics, Rockville, MD) for:
lipocalin-2, TSP-1, TIMP-1, MCP-1, interferon (IFN-γ), interleukin (IL)-1β, IL-4, IL-5, IL-6, KC/GRO, IL-10, IL-13, and
TNF-α.
Immunohistochemistry

Gelatin-coated cover slips of serial tissue sections were
incubated with anti-rabbit (1:100) IL-33 (Cloud-Clone
Corp., Katy, TX) overnight at 4°C, followed by 3
five-minute washes with cold PBS with 0.1% Triton-X.
The sections were then incubated with a FITC conjugated goat anti-rabbit (1:100, Invitrogen, Carlsbad, CA)
at 37°C for one hour, followed by 3 five-minute washes
with cold PBS with 0.1% Triton-X. Cover slips were then
mounted on slides for visualization on a Zeiss fluorescent microscope (Zeiss, Thornwood, NY).
Preparation of cell suspensions

Lungs were perfused with sterile PBS by injection into the
right ventricle to remove remaining blood and then placed
in PBS containing 20 mg/ml Collagenase A, 2.4 U/ml
Dispase II solution, and 50 μl/ml DNAse (Roche, Indianapolis, IN) for 30 min.
The lung tissue was dissociated using the gentleMACS
Octo Dissociator (Miltenyi Biotec, Auburn, CA) and then
centrifuged (1100 x g for 10 min) to collect the sample material. The sample was resuspended with PBS and used for
magnetic cell separation and flow cytometry.
Flow cytometry
Antibodies and reagents

ILC1 and ILC2 numbers 4 h after exposure to nano-TiO2
from lung tissue were determined by flow cytometry as
previously described [57–59]. Briefly, ILC1 were defined
as Lin-CD45 + CD161 + CD335+, while ILC2 were defined
as Lin-CD45 + CD90.1 + KLRG-1 + CD25 + IL1R1 + .
Monoclonal antibodies specific for CD90.1 (FITC),
KLRG1 (APC EFLUOR 780), CD25 (APC), CD161 (PERCP
EFLUOR 710), and CD335 (EFLUOR 450) were purchased
from eBioscience (San Diego, CA). Lineage cocktail (Lin;
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ALEXA FLUOR 700) was used to gate out (CD3, CD14,
CD16, CD19, CD20, and CD56: Biorad, Hercules, CA) CD3
T lymphocytes, CD14 Monocytes, CD16 NK cells, granulocytes, CD19 B lymphocytes, CD20 B lymphocytes, and
CD56 NK cells. Antibodies for CD45 (Cyanine 5) were from
Invitrogen (Carlsbad, CA), while those for IL1R1 (PE) where
from Sino Biologicals (North Wales, PA). Flow cytometry
was performed on a FACSAria (BD Bioscience, Franklin
Lakes, NJ). Data were analyzed with FCS Express 6 Software
(De Novo Software, Glendale, CA).
Isolation of group II innate lymphoid cells

ILC2 were isolated as per manufacturer’s instructions
(Miltenyi Biotec, Auburn, CA). Briefly, lineage-positive
cells were indirectly labeled with a cocktail of ALEXA
FLUOR 700-conjugated antibodies, as primary labeling
reagent, and antibodies conjugated to MicroBeads were
used as secondary labeling reagents. In the second step,
lineage-negative cells were labeled with CD45, CD90.1,
KLRG-1, CD25, and IL1R1, labeled with MicroBeads
and isolated by positive selection from the pre-enriched
lineage negative cell-fraction by separation over a MACS
Column (Miltenyi Biotec, Auburn, CA), which was
placed in the magnetic field of a MACS Separator. After
negative selection, the cells were subsequently eluted as
the positively selected cell fraction containing ILC2.
Cytokine analysis of cell culture media and measurement of
Phospho-NF-ĸB

Isolated ILC2s were incubated (37 °C, 90% humidity, 5%
CO2) overnight in supplemented (10% fetal bovine
serum, 1% penicillin/streptomycin, 1% sodium pyruvate,
1% L-glutamine) Dulbecco’s Modified Eagle Medium
(Corning, Manassas, VA). The following day, the cell
culture medium and cellular portion were separated via
centrifugation (1100 x g for 10 min). IL-4, IL-5, and
IL-13 levels were measured in the cell culture medium
via multi-spot inflammatory assays per manufacturer’s
directions (Meso Scale Diagnostics, Rockville, MD).
Lastly, isolated cells were lysed and phospho-NF-κB
(Ser468 and Ser536) was measured (Meso Scale Diagnostics, Rockville, MD).
Systemic treatment with anti-Interleukin-33 antibody

Rats were treated 1 h prior to pulmonary nano-TiO2 exposure with pharmacological grade polyclonal anti-IL-33
antibody (CAT#ABF108, EMD Millipore, Temecula, CA:
intraperitoneal 1 mg/kg). The antibody and dosage were
selected based on previous murine studies [60]. The
antibody used was a polyclonal anti-IL-33 antibody developed in the rabbit with specific reactivity toward
mouse IL-33 and expected cross reactivity due to the
close homology to rat IL-33. We determined the interspecies homology of the anti-IL-33 target between rats
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and mice to be 87% (Additional file 1: Figure S1).
Plasma, bronchoalveolar lavage fluid, and lung tissue
were obtained 4 h post-exposure from treated animals
for measurement of IL-33. Uterine microvascular assessments were conducted 24 h after treatment in a separate
cohort of animals.
Pressure Myography microvessel preparation

After measuring MAP, the uterus was removed and placed
in a dissecting dish with physiological salt solution (PSS)
maintained at 4 °C. Radial arterioles were isolated, transferred
to a vessel chamber, cannulated between two glass pipettes,
and tied with silk sutures in the chamber (Living Systems Instrumentation, Burlington, VT). The chamber was superfused with fresh oxygenated (5% CO2/21% O2) PSS and
warmed to 37 °C. Arterioles were pressurized to 60 mmHg
using a servo control system and extended to their in situ
length. Internal and external arteriolar diameters were measured using video calipers (Colorado Video, Boulder, CO).
Arteriolar reactivity

Previous work by our group has shown that ENM exposure impacts endothelium-dependent dilation most
severely within 24 h, a condition which has been shown
to improve but did not fully return to control levels after
168 h. Based on these findings, all vascular assessments
for this study were conducted 24 h post-exposure [30].
Arterioles were allowed to develop spontaneous tone, defined as the degree of constriction experienced by a blood
vessel relative to its maximally dilated state. Vascular tone
ranges from 0% (maximally dilated) to 100% (maximal constriction). Vessels with a spontaneous tone ≥20% less than
initial tone were included in this study. After equilibration,
various parameters of arteriolar function were analyzed.
Vessels that did not develop sufficient spontaneous tone
were not included in the data analysis.
Endothelium-Dependent Dilation— arterioles were
exposed to increasing concentrations of acetyl choline
(ACh: 10− 9 - 10− 4 M) added to the vessel chamber.
Endothelium-Independent Dilation—increasing
concentrations of sodium nitroprusside (SNP: 10− 9 10− 4 M) were used to assess arteriolar smooth muscle
responsiveness.
Arteriolar Vasoconstriction—arterioles were exposed
to increasing concentrations of phenylephrine (PE: 10− 9 10− 4 M). The steady state diameter of the vessel was
recorded for at least 2 min after each dose. After each
dose curve was completed, the vessel chamber was
washed to remove excess chemicals by carefully removing
the superfusate and replacing it with fresh warmed
oxygenated PSS. After all experimental treatments were
complete, the PSS was replaced with Ca2+-free PSS until
maximum passive diameter was established.
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Pressure Myography calculations

Data are expressed as means ± standard error. Spontaneous tone was calculated by the following equation:


ðDm−DiÞ
x 100
Spontaneous tone ð%Þ ¼
Di
, where Dm is the maximal diameter and Di is the initial
steady state diameter recorded prior to the experiment.
Active responses to pressure were normalized to the
maximal diameter using the following formula:
Normalized diameter ¼ Dss=Dm
, where Dss is the steady state diameter recorded during
each pressure change. The experimental responses to ACh,
PE, and SNP are expressed using the following equation:
Diameter
maximal diameter Þ
 ðpercent 
ðDss−DconÞ
¼
x 100
ðDm−DconÞ
, where DCon is the control diameter recorded prior to
the dose curve, DSS is the steady state diameter at each
dose of the curve. The experimental response to PE is
expressed using the following equation:
Diameter
maximal diameter Þ
 ðpercent 
ðDcon−DssÞ
¼
x 100
ðDconÞ
Wall thickness (WT) was calculated from the measurement of both inner (ID) and outer (OD) steady state
arteriolar diameters at the end of the Ca2+ free wash
using the following equation:
WT ¼ ðOD−IDÞ=2
Wall-to-lumen ratio (WLR) was calculated using the
following equation:
WLR ¼ WT =ID
Statistics

Point-to-point differences in the dose response curves were
evaluated using two-way repeated measures analysis of variance (ANOVA) with a Tukey’s post-hoc analysis when significance was found. The slopes of the dose response
curves were determined through a nonlinear regression.
The animal characteristics, vessel characteristics and dose
response curve slopes were analyzed using a one-way
ANOVA with a Tukey post-hoc analysis when significance
was found. All statistical analysis was completed with
GraphPad Prism 5 (San Diego, CA) and SigmaPlot 11.0
(San Jose, CA). Significance was set at p < 0.05, n is the
number of arterioles, and N is the number of animals.
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Additional file
Additional file 1: Figure S1. IL-33 sequence homology. Multiple sequence
alignment of the protein sequence of IL-33 in mice (query) and rats (subject)
showing the significant interspecies homology of murine IL-33. (ZIP 259 kb)
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